StockData
AXIM Biotechnologies, Inc. logo

AXIM Biotechnologies, Inc. (AXIM) stock

AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2024, quarter ended Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

AXIM Biotechnologies revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

AXIM Biotechnologies's revenue for the twelve months ending Jun 30, 2024 was $92.90K, up 254.6% year over year. For fiscal 2023 it was $39.52K, up 345.3% from the year before. Over ten years it grew 6.2% a year on average. The highest annual figure on record is $799.48K in fiscal 2019.

Annual revenue

PeriodPeriod endValueChange
FY2023Dec 31, 2023$39.52K+345.3%
FY2022Dec 31, 2022$8.88K-85.3%
FY2021Dec 31, 2021$60.46K–
FY2020Dec 31, 2020$0-100.0%
FY2019Dec 31, 2019$799.48K+308.7%
FY2018Dec 31, 2018$195.61K+311.2%
FY2017Dec 31, 2017$47.57K+1.1%
FY2016Dec 31, 2016$47.06K-4.2%
FY2015Dec 31, 2015$49.14K–
FY2014Dec 31, 2014$0-100.0%
FY2013Dec 31, 2013$21.67K-50.0%
FY2012Dec 31, 2012$43.33K+333.3%
FY2011Dec 31, 2011$10.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2024Jun 30, 2024$17.48K+76.0%
Q1 FY2024Mar 31, 2024$52.98K+616.2%
Q4 FY2023Dec 31, 2023$12.86K+70.1%
Q3 FY2023Sep 30, 2023$9.58K+629.1%
Q2 FY2023Jun 30, 2023$9.93K–
Q1 FY2023Mar 31, 2023$7.40K–
Q4 FY2022Dec 31, 2022$7.56K+57.2%
Q3 FY2022Sep 30, 2022$1.31K-83.8%
Q2 FY2022Jun 30, 2022$0-100.0%
Q1 FY2022Mar 31, 2022$0-100.0%
Q4 FY2021Dec 31, 2021$4.81K–
Q3 FY2021Sep 30, 2021$8.13K–
Q2 FY2021Jun 30, 2021$14.88K–
Q1 FY2021Mar 31, 2021$32.65K–
Q4 FY2020Dec 31, 2020$0-100.0%
Q3 FY2020Sep 30, 2020$0–
Q2 FY2020Jun 30, 2020$0–
Q1 FY2020Mar 31, 2020$0-100.0%
Q4 FY2019Dec 31, 2019$799.48K+378.8%
Q3 FY2019Sep 30, 2019$0-100.0%
Q2 FY2019Jun 30, 2019$0-100.0%
Q1 FY2019Mar 31, 2019$17.06K+19.7%
Q4 FY2018Dec 31, 2018$166.97K+980.2%
Q3 FY2018Sep 30, 2018$6.22K-36.2%
Q2 FY2018Jun 30, 2018$8.17K+118.7%
Q1 FY2018Mar 31, 2018$14.25K-23.5%
Q4 FY2017Dec 31, 2017$15.46K+26.6%
Q3 FY2017Sep 30, 2017$9.76K+1.6%
Q2 FY2017Jun 30, 2017$3.74K-66.7%
Q1 FY2017Mar 31, 2017$18.62K+33.0%
Q4 FY2016Dec 31, 2016$12.21K-20.8%
Q3 FY2016Sep 30, 2016$9.60K-55.6%
Q2 FY2016Jun 30, 2016$11.24K-7.2%
Q1 FY2016Mar 31, 2016$14.01K–
Q4 FY2015Dec 31, 2015$15.42K–
Q3 FY2015Sep 30, 2015$21.61K–
Q2 FY2015Jun 30, 2015$12.11K–
Q1 FY2015Mar 31, 2015$0–
Q4 FY2014Dec 31, 2014$0–
Q3 FY2014Sep 30, 2014$0–

More AXIM Biotechnologies figures

See a number that looks wrong?